These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33097072)

  • 21. Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome.
    Savolainen A; Kupari M; Toivonen L; Kaitila I; Viitasalo M
    J Intern Med; 1997 Mar; 241(3):221-6. PubMed ID: 9104435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-aortic cardiovascular disease in Marfan syndrome: a nationwide epidemiological study.
    Andersen NH; Groth KA; Berglund A; Hove H; Gravholt CH; Stochholm K
    Clin Res Cardiol; 2021 Jul; 110(7):1106-1115. PubMed ID: 33885997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in Cardiovascular Manifestation of Marfan Syndrome Between Children and Adults.
    Wozniak-Mielczarek L; Sabiniewicz R; Drezek-Nojowicz M; Nowak R; Gilis-Malinowska N; Mielczarek M; Łabuc A; Waldoch A; Wierzba J
    Pediatr Cardiol; 2019 Feb; 40(2):393-403. PubMed ID: 30417312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes.
    Tae HJ; Petrashevskaya N; Marshall S; Krawczyk M; Talan M
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H290-9. PubMed ID: 26566724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous Right Ventricular Pseudoaneurysms and Increased Arrhythmogenicity in a Mouse Model of Marfan Syndrome.
    Steijns F; Renard M; Vanhomwegen M; Vermassen P; Desloovere J; Raedt R; Larsen LE; Tóth MI; De Backer J; Sips P
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiomyopathy in Marfan syndrome.
    Hetzer R; Siegel G; Delmo Walter EM
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):561-7; discussion 567-8. PubMed ID: 25755184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study.
    Demolder A; Bianco L; Caruana M; Cervi E; Evangelista A; Jondeau G; Buttigieg LL; López-Sainz Á; Delmás EM; Pini A; Sabaté-Rotés A; Szöcs K; Tchitchinadze M; Teixidó-Tura G; von Kodolitsch Y; Muiño-Mosquera L; De Backer J
    Eur J Med Genet; 2022 Jun; 65(6):104503. PubMed ID: 35427808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the potential relationship between collagen cross-linking and impaired myocardial relaxation in Marfan syndrome: An observational study using serum biomarkers.
    García-Izquierdo E; Mingo-Santos S; Olivo-Rodríguez C; Moñivas-Palomero V; Rivas-Lasarte M; Martín-López CE; Rosado-García S; Sánchez-López AJ; Redondo JM; Rodríguez-Pascual F; Segovia-Cubero J; Forteza-Gil A
    Int J Cardiol; 2022 Apr; 352():125-130. PubMed ID: 35092759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary impairment of left ventricular function in Marfan syndrome.
    De Backer JF; Devos D; Segers P; Matthys D; François K; Gillebert TC; De Paepe AM; De Sutter J
    Int J Cardiol; 2006 Oct; 112(3):353-8. PubMed ID: 16316698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of Arrhythmias and Postural Orthostatic Tachycardia Syndrome in Patients With Marfan Syndrome: A Nationwide Inpatient Study.
    Wafa SEI; Chahal CAA; Sawatari H; Khanji MY; Khan H; Asatryan B; Ahmed R; Deshpande S; Providencia R; Deshmukh A; Owens AT; Somers VK; Padmanabhan D; Connolly H
    J Am Heart Assoc; 2022 Sep; 11(17):e024939. PubMed ID: 36000435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome.
    De Backer J; Loeys B; Devos D; Dietz H; De Sutter J; De Paepe A
    Genet Med; 2006 Jul; 8(7):401-8. PubMed ID: 16845272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography.
    Kiotsekoglou A; Sutherland GR; Moggridge JC; Nassiri DK; Camm AJ; Child AH
    Heart; 2009 Oct; 95(19):1561-6. PubMed ID: 19224905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Cardiac Impairment in Patients With Marfan Syndrome Undergoing a Bentall Procedure.
    Xu H; Jiang W; Joshi Y; Han L; Li H; Lan F; Zhu J; Sun L; Gong M; Zhang H
    Ann Thorac Surg; 2021 Oct; 112(4):1193-1200. PubMed ID: 33307070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders.
    Porciani MC; Giurlani L; Chelucci A; Pepe G; Giusti BH; Brunelli T; Attanasio M; Martinucci P; Fattrori R; Abbatea R; Gensini GF
    Clin Cardiol; 2002 Sep; 25(9):416-20. PubMed ID: 12269520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Florida Sleeve Procedure Is Durable and Improves Aortic Valve Function in Marfan Syndrome Patients.
    Aalaei-Andabili SH; Martin T; Hess P; Klodell C; Karimi A; Arnaoutakis G; Lee T; Beaver T
    Ann Thorac Surg; 2017 Sep; 104(3):834-839. PubMed ID: 28410640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
    Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
    J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse.
    Rippe M; De Backer J; Kutsche K; Mosquera LM; Schüler H; Rybczynski M; Bernhardt AM; Keyser B; Hillebrand M; Mir TS; Berger J; Blankenberg S; Koschyk D; von Kodolitsch Y
    Int J Cardiol Heart Vasc; 2016 Mar; 10():39-46. PubMed ID: 28616514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The main pulmonary artery in adults: a controlled multicenter study with assessment of echocardiographic reference values, and the frequency of dilatation and aneurysm in Marfan syndrome.
    Sheikhzadeh S; De Backer J; Gorgan NR; Rybczynski M; Hillebrand M; Schüler H; Bernhardt AM; Koschyk D; Bannas P; Keyser B; Mortensen K; Radke RM; Mir TS; Kölbel T; Robinson PN; Schmidtke J; Berger J; Blankenberg S; von Kodolitsch Y
    Orphanet J Rare Dis; 2014 Dec; 9():203. PubMed ID: 25491897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1C1039G/+ model and longitudinal findings in humans.
    Campens L; Renard M; Trachet B; Segers P; Muino Mosquera L; De Sutter J; Sakai L; De Paepe A; De Backer J
    Pediatr Res; 2015 Sep; 78(3):256-63. PubMed ID: 26042521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?
    Yetman AT; Bornemeier RA; McCrindle BW
    J Am Coll Cardiol; 2003 Jan; 41(2):329-32. PubMed ID: 12535830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.